Corticosteroid use in special circumstances: preterm ruptured membranes, hypertension, fetal growth restriction, multiple fetuses.
Bloom
Steven L
SL
Department of Obstetrics and Gynecology, The University of Texas Southwestern Medical Center, Dallas 75390-9032, USA. Steven.Bloom@utsouthwestern.edu
Leveno
Kenneth J
KJ
D001623:Betamethasone / Q000009:adverse effects / Q000627:therapeutic use*; D015975:Consensus Development Conferences, NIH as Topic; D019317:Evidence-Based Medicine; D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy; D005317:Fetal Growth Retardation / Q000188:drug therapy*; D005322:Premature Rupture of Fetal Membranes / Q000188:drug therapy*; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007231:Infant, Newborn; D007234:Infant, Premature / Q000502:physiology; D011225:Pre-Eclampsia / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011272:Pregnancy, Multiple / Q000187:drug effects*; D014481:United States
D005938:Glucocorticoids; D001623:Betamethasone